Selected article for: "molecular mechanism and RNA virus"

Author: Milewska, Aleksandra; Kindler, Eveline; Vkovski, Philip; Zeglen, Slawomir; Ochman, Marek; Thiel, Volker; Rajfur, Zenon; Pyrc, Krzysztof
Title: APOBEC3-mediated restriction of RNA virus replication
  • Cord-id: ysspkbj7
  • Document date: 2018_4_13
  • ID: ysspkbj7
    Snippet: APOBEC3 family members are cytidine deaminases with roles in intrinsic responses to infection by retroviruses and retrotransposons, and in the control of other DNA viruses, such as herpesviruses, parvoviruses and hepatitis B virus. Although effects of APOBEC3 members on viral DNA have been demonstrated, it is not known whether they edit RNA genomes through cytidine deamination. Here, we investigated APOBEC3-mediated restriction of Coronaviridae. In experiments in vitro, three human APOBEC3 prote
    Document: APOBEC3 family members are cytidine deaminases with roles in intrinsic responses to infection by retroviruses and retrotransposons, and in the control of other DNA viruses, such as herpesviruses, parvoviruses and hepatitis B virus. Although effects of APOBEC3 members on viral DNA have been demonstrated, it is not known whether they edit RNA genomes through cytidine deamination. Here, we investigated APOBEC3-mediated restriction of Coronaviridae. In experiments in vitro, three human APOBEC3 proteins (A3C, A3F and A3H) inhibited HCoV-NL63 infection and limited production of progeny virus, but did not cause hypermutation of the coronaviral genome. APOBEC3-mediated restriction was partially dependent on enzyme activity, and was reduced by the use of enzymatically inactive APOBEC3. Moreover, APOBEC3 proteins bound to the coronaviral nucleoprotein, and this interaction also affected viral replication. Although the precise molecular mechanism of deaminase-dependent inhibition of coronavirus replication remains elusive, our results further our understanding of APOBEC-mediated restriction of RNA virus infections.

    Search related documents:
    Co phrase search for related documents
    • accession number and active protein: 1, 2
    • accession number and acute sars cov respiratory syndrome coronavirus: 1, 2, 3
    • acid isolation and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6
    • active protein and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • active protein and additional mechanism: 1
    • active protein and low stability: 1
    • active protein and macrophage monocyte: 1
    • acute sars cov respiratory syndrome coronavirus and additional mechanism: 1, 2, 3, 4, 5
    • acute sars cov respiratory syndrome coronavirus and localisation co: 1
    • acute sars cov respiratory syndrome coronavirus and log reduction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars cov respiratory syndrome coronavirus and low stability: 1, 2, 3, 4, 5, 6
    • acute sars cov respiratory syndrome coronavirus and macrophage monocyte: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • localisation co and macrophage monocyte: 1